Cubist Pharmaceuticals (United States)
Cubist Pharmaceuticals, Inc. was an American biopharmaceutical company that targeted pathogens like MRSA. . The company employed 638 people, mostly in Lexington, Massachusetts. On 8 December 2014, Merck & Co. acquired Cubist for $102 per share in cash. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Cubist Pharmaceuticals (United States), United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
44%
Total
Publications
576
Total Open
Publications
255
Total
Citations
38K
Open Access
Percentage
44%
Total
Publications
576
Total Open
Publications
255
Total
Citations
38K
Breakdown
Publisher Open
16%
Both
14%
Other Platform Open
14%
Closed
56%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 18%
32
Hybrid 23%
39
No Guarantees 59%
102
Other Platform Open
Domain 93%
149
Public 11%
17
Institution 9%
15
Other Internet 4%
7
Preprint 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 149 |
Europe PMC | Domain | 127 |
Semantic Scholar | Public | 16 |
University College London - UCL Discovery | Institution | 7 |
CiteSeer X | Other Internet | 7 |
University of Michigan - Deep Blue | Institution | 4 |
Ludwid Maxmilian's Universitat Munchen - Open access LMU | Institution | 2 |
Harvard University - Digital Access to Scholarship at Harvard (DASH) | Institution | 2 |
whiterose.ac.uk OAI-PMH Repository | Institution | 1 |
University of Waterloo - UWSpace | Institution | 1 |